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In vivo interaction of specific antibodies with circulating protein antigens leads to 
the formation of antigen-antibody complexes and both antigen and antibody are sub- 
sequently removed from the circulation  (1). Complexes formed near equivalence  or in 
antibody excess are very rapidly eliminated from the circulation,  whereas complexes 
formed in far antigen excess persist in the circulation  for a prolonged period of time, 
but are eliminated faster than either antigen or antibody when injected alone (2). 
Recent studies on the structure of -yO-immunoglobnlins have shown  that complexes 
can be formed in vitro with certain fragments and polypeptide chains of "tG-antibodies. 
Fab fragments which contain only one antibody-combining site (3) form soluble com- 
plexes with antigen, whereas F (abe2 fragments which contain two antibody-combining 
sites form insoluble  complexes with antigen (4). The formation of soluble complexes 
between antigen and specific H chains has been demonstrated (5-9), whereas conflict- 
ing findings have been reported concerning  complex formation involving L chains  (5, 
8-10). 
It is of both theoretical and practical interests whether complexes between 
antigen  and  antibody subunits  are  formed in  vivo.  The present  experiments 
have been designed to study the in vivo formation and subsequent fate of com- 
plexes formed between a protein antigen and the fragments and the polypeptide 
chains  of specific rabbit ~,G-antibodies. It has been previously demonstrated 
that in the absence of specific antigen, fragments and polypeptide chains of ~/G- 
immunoglobulins which lack the Fc portion of the H  chain are rapidly elimi- 
nated from the circulation and catabolized (11,  12). In the present experiments 
~,G-subunits were injected into either rabbits or guinea pigs immediately follow- 
ing the injection of specific antigen. To follow the formation and in vivo fate of 
complexes, either the antigen or the ),G-subunit prepared from purified anti- 
bodies was labeled with  1  a81 and their elimination from the circulation followed. 
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Materials and Methods 
Animals.--New Zealand rabbits,  weighing approximately 2 kg and guinea pigs weighing 
500 g were used in the experiments. All animals were fed Purina chow and water containing 
KI. 
Antigens.--Crystalllne  bovine  serum  albumin  (BSA),  lot  X69508,  was  obtained  from 
Armour  Pharmaceutical  Co.,  Kankakee,  Illinois.  Guinea pig serum  albumin  (GpSA)  was 
prepared from normal guinea pig serum according to a method previously described (13). 
Antisera.--Anri-bovine  serum  albumin  (anti-BSA)  and  anti-guinea  pig serum  albumin 
(anti-GpSA) was obtained from rabbits given several series  of injections of BSA or GpSA, 
each series totaling 180 rag.  The rabbits were bled 7 days after the last injection and their 
sera pooled. 
Isolation of 5'G.--The ~/G-globulin  fraction of rabbit antisera or normal rabbit serum was 
isolated by combined ammonium sulfate precipitation and DEAE-cellulose chromatography 
as previously described (11). 
Purification  of Ant~ibodies.--Purified anti-BSA and  anri-GpSA antibodies  were prepared 
from the ^/G-fmcrion according to the method described by Weliky et ah  (14). 90 to 95% of 
the  protein  representing  the  purified  antibodies  was  precipitated  with  the  corresponding 
antigen. The in vivo behavior of purified anti-BSA antibodies was similar to the anti-BSA 
~/G-preparation obtained by DEAE-cellulose chromatography. Purified I131-1abeied antibodies 
injected into rabbits  in  the absence  of antigen  were eliminated from the circulation and 
catabolized  at  a  similar  rate  as  nonanribody  '}'G-preparations.  I131-labeled  BSA injected 
intravenously into rabbits was rapidly and completely eliminated from the circulation after a 
subsequent injection of 1.3 rimes the equivalence amount of purifed anti-BSA. 
Iodination  with I131.--5 nag afiquots of either BSA, TG, Fab, or F(ab~)~ fragments were 
labeled with I TM (I*) according to the method described by McConahey and Dixon (15). 
Papain and Pepsin Digestion of'),G.---TG and purified antibodies were digested with twice 
crystallized papain (Worthington Biochemical Corporation, Freehold, New Jersey) according 
to the method described by Porter (3), except that the duration of digestion was limited to 4 
hr.  Fab fragments were isolated by carboxymethylceUulose chromatography,  using 0.01 x¢, 
pH 5.5, acetate buffer (3). Pepsin digestion of either "yG or purified antibodies was performed 
with  twice crystallized  pepsin  (Worthington  Biochemical  Corporation)  according  to  the 
method described by Nisonoff et al. (4).  Fifty-four to 58% of the original anti-BSA precipi- 
taring activity was recovered in the pepsin digest. 
Preparation of H  and L Chains.--H and L chains were isolated from purified anti-BSA or 
nonspecific TG according to the method  described by Fleischman et al.  (16) using 0.15 M 
mereaptoethylamine and  0.2 M iodoacetamide for the reduction and  alkylation procedures. 
After isolation by Sephadex G-75 gel filtration in 1 N propionic acid, the H and L chains were 
concentrated  by pressure  dialysis and  dialyzed against  phosphate-buffered  saline  pH  7.0. 
The concentration of the H  chains was kept below 200  ~g per ml pH  7.0  buffered  saline 
because of their low solubility at neutral pH. Examination of isolated H and L chain prepara- 
tions by starch gel electrophoresis in 8 M urea at pH 2.9 (17) did not reveal any intact TG in 
the H and L chain preparations. In all instances when I* H and L chins were used, the puri- 
fied  anti-BSA or nonspecific TG-preparations  were  first  labeled  with  I*,  followed by  the 
isolation of H  and L  chains.  Seventy-one to 73% of the I* activity was recovered in the H 
chain fraction and 27 to 29% in the L chain fraction. 
Preparation of Hybrid  Molexules.--Hybrid  "yG-molecules  were prepared according to the 
method described by Olins and Edelman (18). Equal amounts of I*-labeled purified anti-BSA 
and  I*-labeled nonspecific rabbit TG were reduced,  alkylated,  and  their H  and  L  chains 
separated. The H  and L chain fractions were divided into two equal parts while still in pro- 
pionic acid. Four mixtures were made of one part H chains and one part L chains; e.g.  specific 
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chains plus specific L chains and nonspedfic H and L chains. The mixtures were subsequently 
concentrated by pressure dialysis and dialyzed against phosphate-buffered  saline pH 7.0. A 
slight precipitate which formed after dialysis was removed by centrifugation. The preparations 
containing hybrid "yG-molecules were subsequently digested with papain and the Fab frag- 
ments isolated. 
Preparation of Fd Fragmotts.--Fd  fragments were isolated from reduced  and  alkylated 
I*-labeled Fab fragments by Sephadex G-75 gel filtration in 1 N propionic acid as described 
by Fldschman et al. (5). The ascending portion of the first major protein peak representing 
dimetized Fd fragments and the descending portion of the second protein peak representing L 
chains were used in the experiments. The concentration of the Fd fragments was kept below 
100 pg per mlpH 7.0 buffered saline because of their relatively low solubility at neutral pH. 
No contamination of the Fd fragments with L chains could be demonstrated by Ouchterlony 
analysis with a guinea pig antiserum to rabbit L chains. 
Elimi~  from the Circulation.--I*-labeled or unlabeled BSA was injected intravenously 
into rabbits followed 5 rain later by the injection of tither labeled or unlabeled "yG or ~,G- 
subunits.  1 nag of I*-labded "yG-subunits were injected into guinea pigs by cardiac puncture. 
The elimination from the circulation of tither I*-labded antigen or ~,G-subunits was deter- 
mined as previously described (ii). The elimination curves shown in Figs. I to 7 represent an 
average of determinations from data obtained from 6 to 8 animals. 
Analysis  of A~is~ra.--Rabbit  anti-BSA and  anti-GpSA ")'G-antibody preparations  were 
analyzed for precipitating antibody using a  quantitative precipitin technique employing I* 
antigen  (19).  Purified antibody  preparations  were analyzed by the quantitative precipitin 
analysis technique described by Hddelberger and Kendall (20).  Protein nitrogen determina- 
tions were performed by a  modification of the micro-Kjeldahl technique using a  Technieon 
auto-analyzer (21). 
RESULTS 
Effect  of 7G-Fragments  of Anti-BSA  on Elimination of BSA.--Rabbits were 
injected intravenously with 2 mg  I*BSA followed $ min later by 12 mg anti- 
BSA 7G (1.1 times equivalence) or 12 mg anti-BSA digested with either papain 
or pepsin and the elimination from the circulation  of the I*BSA  was followed. 
As expected, the Fab preparation did not precipitate BSA in vitro, whereas the 
F  (ab'),  preparation retained 58 % of its original  precipitating capacity. As 
shown in Fig. 1, the I*BSA was completely eliminated from the circulation after 
injection of'yG-anti-BSA. Five of 6 rabbits showed a mild anaphylactic reaction 
5 to 15 min after injection of anti-BSA. Injection of either Fab or F (ab')2 frag- 
ments did not cause an immune elimination of I*BSA and none of the rabbits 
showed signs of anaphylaxis.  When compared  with control rabbits  receiving 
only I*BSA, significantly more I*BSA remained in the intravascular compart- 
ment in rabbits injected with either anti-BSA  Fab or F  (ab')~ fragments. The 
I*BSA was eliminated after initial equilibration  at an exponential  rate with a 
half-life of 4.5 to 5.0 days both in control rabbits and in rabbits receiving anti- 
BSA Fab and F (ab')2 fragments. Most of the rabbits which received anti-BSA 
Fab and F (ab')~ fragments showed an immune elimination of the BSA 7 to 10 
days after injection, whereas control rabbits injected with only BSA showed an 
immune elimination 10 to 14 days after injection of the I*BSA. 
The effect of increasing amounts of Fab and F (ab')2 fragments on the elim- 1002  ANTIGEN-ANTIBODY COMPLEXES 
ination of 2 mg I*BSA was studied by injecting fragments which were prepared 
from 24 and 48 mg anti-BSA 3'G (2.2 and 4.4 times equivalence). The prepara- 
tions of F  (ab')~ fragments prepared from 24 and 48 mg anti-BSA completely 
precipitated 2 mg of I*-labeled BSA in vitro, whereas the Fab preparations had 
no precipitating activity. The elimination curves of I*BSA after injection of 
these amounts of Fab and F  (ab')~ fragments is shown in Fig.  2. Injection of 
Fat) fragments obtained from 24 and 48 mg anti-BSA did not cause an immune 
elimination of the I*BSA and again more I*BSA remained in the intravascular 
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FIG.  1.  Effect  of  1.1  times equivalence 3"C--'~nfi-BSA  and  F(ab%  and  FaD  fragments 
obtained from 1.1 times equivalence anfi-BSA on the elimination of P-labeled BSA from the 
circulation of rabbits. 
compartment  as  compared  to  control  rabbits  receiving  only I*BSA.  The 
rate of elimination of I*BSA after initial equilibration was similar to the rate of 
elimination of I*BSA in control rabbits. In contrast, F (ab')~ fragments obtained 
from 24 and 48 mg anti-BSA caused an accelerated elimination of the I*BSA. 
The rate of elimination of I*BSA, however, was slower than that observed after 
injection of intact 3tG-antibody and not all of the I*BSA was eliminated from 
the circulation. The I*BSA was eliminated after injection of 24 mg TG--anti- 
BSA with a half-life of approximately 1 rain. The elimination curves of the I*- 
BSA during the first 60 min after injection of F  (ab'),. fragments obtained from 
24 and 48 mg anti-BSA indicated that the complexes formed between I*BSA 
and F (ab')~ fragments were heterogenous in respect to their rate of elimination. 
Some complexes might have been elimated as fast as complexes formed by intact HANS  L.  SPIEGELBERG  AND  WILLIAM  O.  WEIGLE  1003 
~'G, whereas others appeared to be more slowly eliminated or not elimlnated at 
all. In any event, more complexes were rapidly eliminated with the 48 mg dose 
than with the 24 mg dose of F (abr)~ fragments. 
Elimination  of Fab and F  (ab')~ Fragments of Purified AnE-BSA in Presence 
and Absence of BSA.--The finding that more I*BSA remained  in theintravascu- 
lar compartment in rabbits injected with Fab or F  (ab')~ fragments (in slight 
antigen excess) compared to rabbits injected with only BSA suggested that the 
anti-BSA fragments formed complexes in vivo with BSA which persisted in the 
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I~G.  2.  Effect  of  2.2  times equivalence TG--anti-BSA and  F(ab')~ and  Fab  fragments 
obtained from 2.2 and 4.4 times equivalence anti-BSA on the elimination of I*-labeled BSA 
from the circulation of rabbits. 
circulation.  I*-labeled  Fab and F  (ab')~ fragments of purified anti-BSA  were~ 
therefore,  injected into rabbits which first received intravenous injections  of 
either 500 mg BSA or thesamevolumeof  0.15 ~ NaC1 (Fig. 3). Fab and F  (ab')2 
fragments were rapidly eliminated from the circulation in the absence of BSA. 
In the presence of BSA, anti-BSA Fab, and F  (ab')2 fragments  remained in the 
circulation  for long periods of time. After initial equilibration  they were elimi- 
nated at an exponential  rate with a  half-life of approximately 5  days. The 
I*-labeled  Fab and F  (ab')~ fragments were more rapidly eliminated 8 to 12 
days after injection as a result of the immune elimination of BSA by the host. 
Elimination of H and L Chains of Purified Anti-BSA in Presence and Absence 
of BSA.--Preparations of H and L chains isolated from 10 mg I*-labeled puri- 
fied anti-BSA were injected into rabbits which previously received an intra- 1004  ANTIGEN-ANTIBODY  COMPLEXES 
venous injection  of either  500  mg BSA  or  an  equal volume of 0.15 ~  NaC1 
(Fig. 4). In the absence of BSA, the H  chains, after initial equilibration, were 
slowly eliminated, whereas the L  chains were very rapidly e]imlnated.  In the 
presence of BSA,  slightly more H  chains remained in the intravascular  com- 
partment as compared to H  chains injected into control rabbits and 8  to  12 
days after injection,  the I* H  chains were more rapidly eliminated as a result 
of the immune elimination of the BSA by the host. The L  chains were rapidly 
and similarly eliminated both in rabbits receiving BSA and in control rabbits 
receiving no BSA. Even the rate of elimination which occurred as early as 5 to 
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FIG. 3.  Ellm;nation of I*-labeled Fab and F(ab% fragments of purified anti-BSA from 
the circulation of rabbits receiving 500 mg BSA and rabbits receiving no BSA. 
30 rain following injection was similar in both presence and absence of BSA. 
Incubation of I*-labeled H  and L  chains for 24 hr with BSA prior to the injec- 
tion resulted  in similar elimination  curves. Again, no difference between  the 
rate of elimination of the L chains in presence and absence of BSA was observed. 
To determine whether excess specific H  chains would cause a rapid elimina- 
tion of BSA, 0.15 mg I*BSA was incubated in vitro for 4  hr at pH 7.0  with 
either 15 mi saline or 15 ml saline containing either 1.5 mg H  chains or 3.0 mg H 
chains  obtained from purified anti-BSA.  The mixtures were subsequently in- 
jected into rabbits and the elimination of the I*BSA followed. The I*BSA which 
had  been  incubated  with  specific H  chains  was  slowly  eliminated  from  the 
circulation,  similar to I*BSA which had been incubated with saline.  Slightly HANS  L.  SPIEGELBERG  AND  WILLIAM  O.  WEIGLE  1005 
more I*BSA incubated with H chains remained in the intravascular spaces as 
compared to I*BSA incubated with saline. Similar findings were obtained in 
rabbits injected with 0.15 mg I*BSA followed 5 min later by injections of 1.5 
or 3.0 mg isolated H chains of purified anti-BSA. 
Elimination of Fd Fragments of Anti-BSA in Presence and Absence of BSA.-- 
Fd fragments and L chains prepared from I*-labeled Fab fragments of purified 
anti-BSA were injected into rabbits which previously received either 500 mg 
BSA or an equal volume of 0.15 M NaCI (Fig. 5). In the absence of BSA both 
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FIG. 4.  Ellmlnation of I*-labeled H  and L chains of purified anti-BSA from the circulation 
of rabbits receiving 500 mg BSA and rabbits receiving no BSA. 
Fd fragments and L  chains were rapidly eliminated,  while in the presence of 
BSA Fd fragments remained in the circulation and were eliminated with a half- 
life of approximately 5 days. The Fd fragments were more rapidly eliminated 
9 to 12 days after injection as a result of an immune response of the host to the 
BSA. L chains prepared from Fab fragments were rapidly eliminated both in 
presence and absence of BSA. 
Elimination of Hybrid Fob Fragments in Presence and Absence of BSA.--In 
order to determine the contribution of specific L chains and Fd fragments in 
the binding of the Fab fragments to the circulating  BSA, Fab fragments ob- 
tained from hybrid ~,G-molecules, containing either H or L chains from specific 
anti-BSA and the corresponding chain from nonspecific ~/G were injected into 
rabbits previously injected with 500 mg BSA (Fig. 6). In the absence of BSA 
all  preparations  of hybrid  Fab  fragments were  rapidly eliminated.  In  the 1006  ANTIGEN-ANTIBODY COMPLEXES 
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FIG. 5.  Elimination of I*-labeled Fd fragments and L  chains of purified anti-BSA from 
the circulation of rabbits receiving 500 mg BSA and rabbits receiving no BSA.  ,oo  
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Fze. 6.  Elimination of I*-labeled Fab hybrids from the circulation of rabbits receiving 500 
mg BSA and rabbits receiving no BSA. H B, L B  =  H  or L chains derived from purified anti- 
BSA; H, L  =  H  or L chains derived from nonspecific rabbit "yG. HANS  L.  SPIEGELBERG  AND  WILLIAM  O.  W'E1GLE  1007 
presence of BSA, Fab hybrids containing  a  specific Fd fragment and either a 
specific or a  nonspecific L  chain  remained  in  the  circulation  with  the  BSA. 
In  contrast,  Fab hybrids containing  a  specific L  chain  and  a  nonspecific Fd 
fragment were rapidly eliminated in a similar manner as the Fab hybrids con- 
taining  both nonspecific Fd fragments  and L  chain.  Less of the Fab hybrids 
containing a specific Fd fragment remained in the circulation  (Fig. 6) in pres- 
ence of BSA as compared to untreated Fab fragments (Fig. 3). The elimination  °k 
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FIG. 7. El;mination of I*-]abeled Fab fragments, H and L chains of purified rabbit ant;- 
GpSA and of nonspec/fic  rabbit ~'G from the drculation of g.me~ pigs. 
from  the  circulation  of specific Fab fragments  which  had  been reduced  and 
alkylated only and Fab fragments which had been dialyzed against propionic 
acid after reduction and alkylation was therefore studied and compared with 
the elimination  of untreated  Fab fragments.  In the presence of BSA, reduced 
and  alkylated  Fab fragments  (but not dialyzed against  propionic acid)  were 
eliminated in a similar manner as untreated Fab fragments. However, following 
dialysis  of the  reduced  and  alkylated  Fab  fragments  against  propionic  acid 
they were eliminated  similarly  to Fab hybrids containing  a  specific Fd frag- 
ment. 
Elimination  of "),G-Subunit~ of both Purified  Rabbit  Anti-GpSA  and  Non- 
specific Rabbit ~tG in Guinea Pigs.--Since no complex formation between anti- 
BSA L chains and BSA was observed in rabbits, L chains of purified anti-GpSA 1008  ANTIGEN-ANTIBODY  CO~[PLEX~S 
were injected into guinea pigs in order to have a maximum in vivo concentra- 
tion of antigen.  Fab fragments and H  chains of purified  anti-GpSA and non- 
specific rabbit TG also were injected into guinea pigs (Fig. 7). Fab fragments, 
H  and L  chains obtained from nonspecific  rabbit ~/G were rapidly eliminated 
from the circulation of guinea pigs.  Fab fragments and H  chains of purified 
anti-GpSA  remained  in  the  circulation  and  were  catabolized  after  initial 
equilibration with a half-life of approximately 3.5 days; a half-life  characteristic 
of GpSA. No immune elimination of Fab fragments and H chains was observed. 
L chains obtained from purified anti-GpSA which had been injected into guinea 
pigs or incubated in vitro with GpSA prior to the injection were rapidly elimi- 
nated, similar  to nonspecific L chains. 
DISCUSSION 
The present data demonstrate that certain subunits of TG-antibodies react 
in vivo and form complexes with circulating protein antigens.  These complexes 
usually persist in  the circulation and  are eliminated with a  half-life  charac- 
teristic  of the antigen.  The in vivo fate of complexes  formed with subunits 
differs  from the fate of complexes formed with TG. Although certain soluble 
complexes formed with TG-antibodies also remain in the circulation for a pro- 
longed period of time, they are eliminated faster than either antigen or antibody 
injected separately (2). The in vivo reaction of'yG-subunits with specific antigen 
and the persistence of the resulting complexes in the circulation appears to be 
an example of a protein-protein interaction resulting in a  complex whose rate 
of elimiuation is governed by only one of the reactants. 
The Fc fragment,  which is not a  part of the antibody-combining site  (3), 
appears to be indirectly involved in the immune elimination  of antigen-antibody 
complexes.  Complexes  formed by Fab and Fd fragments, which both lack the 
Fc fragment,  remained in the circulation with the antigen.  Most of the com- 
plexes formed by F (abe)2 fragments, which also lack the Fc fragment, but still 
precipitate with antigen, were less effectively eliminated than complexes formed 
by intact ~/G. Furthermore,  complexes formed by F  (ab09 fragments in slight 
antigen excess remained in the circulation with the antigen and were eliminated 
at the same rate as the antigen. It has been shown that the structure responsible 
for the complement-fixing  property of TG is localized mainly in the Fc fragment 
(22,  23).  A  rapid immune elimination  of bacteria and  erythrocytes depends, 
in part, on both antibody and complement (24, 25). Complement may also play 
a  role in  the immune  elimination  of antigen-antibody complexes  formed by 
protein antigens. Fab fragments which no longer fix complement did not cause 
an immune elimination of the antigen, whereas F (abe)2 fragments which retain 
a  small ability to fix complement (23),  eliminated the antigen less effectively 
than intact TG. However, isolated specific H chains which contain the Fc frag- 
ment did not cause an immune elimination  of the antigen. The H chains might HANS  L.  SPIEGELBERO  AND  WILLIAM  O.  WEIOLE  1009 
have become altered  during  the isolation procedure, resulting  in loss  of the 
phagocytosis promoting action related to the Fc portion of the H  chain.  Physi- 
cochemical changes of the antibodies occurring during the complex formation 
such as the formation  of insoluble complexes  also have to be considered as 
factors which enhance phagocytosis of antigen-antibody complexes. 
The elimination from the circulation of ~G-subunits in presence and absence 
of specific antigen offers a system to study the ability of ~G-subunits to bind to 
antigen in vivo. In the absence of antigen, all "yG-subunits lacking the Fc por- 
tion of the H  chain are rapidly eliminated from the circulation and catabolized 
(11, 12). In the presence of excess antigen, specific Fab and F (abl)~ fragments, 
both known to contain one and two antibody-combining sites respectively (3, 4), 
remained in the circulation.  Similarly, Fd fragments, either as Fd dimers or in 
combination with a nonspecific L chain in Fab hybrids remained in the circula- 
tion with the antigen. Although isolated H chains remained in the circulation of 
rabbits in the absence of antigen, specific H  chains formed complexes with the 
antigen. After equilibration, more H  chains which formed complexes remained 
in the intravascular compartment than H  chains injected alone and when the 
characteristic immune elimination of the antigen occurred, the specific H chains 
were eliminated rapidly with the antigen. In guinea pigs nonspecific H  chains 
were rapidly eliminated  from  the  circulation,  whereas,  specific H  chains  re- 
mained in the circulation with the antigen. In contrast to H  chains,  specific L 
chains did not appear to bind to the antigen in vivo. Either isolated specific L 
chains or specific L chainR present in Fab hybrids containing a nonspecific  Fd 
fragment were eliminated rapidly in both presence and absence of antigen. The 
present findings on the ability of ~,G-subunits  to bind to an antigen in vivo are 
in agreement with those reported by investigators employing an in vitro system 
with a relatively high over-all recovery. These authors found that the ability to 
bind to an antigen remained with both the H chain and the Fd portion of the H 
chain, whereas theL chain did not bind significantly to antigen (5-8, 26). However, 
indirect evidence of binding of L chains to antigen (9, 10) as well as contribution 
of the L chains to the antibody-combining site have been reported (27, 28). In 
the present experiments,  a possible binding of specific L chains to the antigen 
should have resulted, at least, in a temporary delay in its elimination from the 
circulation.  However, no such delay was observed. Although these experiments 
do not exclude  a  contribution of the L  chain to the antibody-combining site, 
they suggest that a specific contribution, if any, is small. 
Although ~,G-subunits  interact with antigens in vivo, the present and pre- 
vions data (11) on the in vivo behavior of "yG-subunits suggest that their use as 
prophylactic and therapeutic agents is limited.  A prophylactic effect of Fab and 
F  (ab')~ fragments can only be brief since they are rapidly eliminated  and  ca- 
tabolized in a host in the absence of antigen. A therapeutic effect can be expected 
if their function is to inactivate toxic sites of antigens, such as diphtheria and 1010  ANTIGEN-ANTIBODY  COMPLEXES 
tetanus toxins. However, if the therapeutic effect depends on the removal from 
the circulation of antigens, Fab fragments are ineffective and F (abe)2 fragments 
apear to be only partially effective in antibody excess. 
Nonspecific H  chains obtained from rabbit 7G persisted in the circulation of 
rabbits but were rapidly eliminated from the circulation of guinea pigs.  The 
rapid elimination of heterologous nonspecific H chainsin guinea pigs might be the 
result of the ability of guinea pigs to excrete larger amounts of 7G-fragments in 
the urine (11) as well as an apparent unique catabolism of 7G in this species 
(29). 
The rates of disappearance of both H and L chains from the circulation could 
be affected by the presence of contaminations. H  chain preparations are difl~- 
cult to obtain free of L  chains which could recombine with H  chains forming 
either intact  7G-globulin or half-molecules. The maximum contamination of 
the H  chain preparations used in the present study was no greater than 10 to 
15% and probably less.  A  40%  contamination, however, would be necessary 
to explain the persistence of H chains in the circulation of rabbits. The L chain 
preparations did not contain significant amounts of H  chains, since following 
injection more than 95 %  of the r 81 activity of the L  chain preparations was 
rapidly eliminated from the circulation. 
SUMMARY 
The in  vivo formation and subsequent fate  of complexes formed betwecn spe- 
cific  rabbit 7G-antibody subunits and circulating  protdn antigens was studied 
in rabbits and guinea pigs.  Subunits obtained from purified  antibodies were in- 
jected immediately after  an injection  of antigen, and the elimination from the 
circulation  of tither  l*-labeled  7G-subunits or labeled  antigen determined. 
In the absence of antigen,  all  7G-subunits which lack the Fc fragment wcrc 
rapidly eliminated.  In the presence of  excess  antigen,  F (ab')2,  Fab and Fd frag- 
ments reacted with antigen and remained in the circulation  as complexes which 
wcrc eliminated at the same rate  as the antigen. Fab hybrids containing a spe- 
cific  Fd fragment and a nonspecific  L  chain similarly  reacted with antigen and 
remained in the circulation  complexed to antigen.  In contrast,  L chains and Fab 
hybrids containing a specific  L chain and a nonspecific  Fd fragment did not re- 
act with antigen in vivo and were rapidly eliminated in both presence and ab- 
sence of antigen.  H  chains remained in the circulation  of rabbits  in the absence 
of antigen, however, in the presence of antigen,  more I-I chains which formed 
complexes with antigen remained in the intravascular space and wcrc rapidly 
eliminated when the immune elimination of the antigen by the host occurred. 
Nonspecific H  chains were rapidly eliminated from the circulaion of guinea 
pigs,  whereas specific  H chains remained in the circulation  with the antigen. 
F (ab')s  fragments formed complexes with antigen near antibody equivalence 
and in antibody excess which were rapidly eliminated,  however, less  effectively HANS  L.  SPIEGELBERG  AND  WILLIAM O.  WEIGLE  1011 
than complexes formed near antibody equivalence with intact yG. Complexes 
formed in antibody excess between Fab fragments and H chains remained in the 
circulation at all concentrations studied and were eliminated at the rate of anti- 
gen. 
The role of the Fc fragment in the immune elimination of antigen-antibody 
complexes is discussed. 
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